You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 203 No. 13, March 25, 1968 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Studies on Induced Influenza in Man

II. Double-Blind Study Designed to Assess the Prophylactic Efficacy of an Analogue of Amantadine Hydrochloride

Albert T. Dawkins, Jr., MD; Lawrence R. Gallager, MD; Richard B. Hornick, MD; Barton A. Harris, MD

JAMA. 1968;203(13):1095-1099.


Abstract

A single double-blind study conducted with 55 volunteers showed clearly that Exp 126 (alpha-methyl-1-adamantanemethylamine hydrochloride, rimantadine hydrochloride), an analogue of amantadine hydrochloride, reduced the occurrence and severity of artificially induced Asian influenza in humans. The infection (or seroconversion) rate in the drug-dosed and placebo-dosed groups was almost 100%, although the increase in serum neutralizing antibody levels was significantly less in the Exp 126-dosed subjects. The infecting influenza virus was recovered only from placebo-dosed controls. Probable untoward reactions from the drug occurred in three volunteers. Two related drugs, amantadine hydrochloride and rimantadine hydrochloride are now available for the prevention of Asian influenza.



Author Affiliations

From the Division of Infectious Diseases, Department of Medicine, University of Maryland School of Medicine, Baltimore.


Footnotes

Reprint requests to 29 S Greene St, Baltimore 21201 (Dr. Togo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Influenza: vaccination and treatment
Stephenson and Nicholson
Eur Respir J 2001;17:1282-1293.
ABSTRACT | FULL TEXT  

Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza: Randomized Controlled Trials for Prevention and Treatment
Hayden et al.
JAMA 1999;282:1240-1246.
ABSTRACT | FULL TEXT  

Chemotherapeutic control of influenza
Stephenson and Nicholson
J Antimicrob Chemother 1999;44:6-10.
FULL TEXT  

Safety and Efficacy of the Neuraminidase Inhibitor GG167 in Experimental Human Influenza
Hayden et al.
JAMA 1996;275:295-299.
ABSTRACT  

Effectiveness of Rimantadine Prophylaxis of Children Within Families
Clover et al.
Arch Pediatr Adolesc Med 1986;140:706-709.
ABSTRACT  

Cyclooctylamine of Experimental in the Prevention Human Influenza
Togo et al.
JAMA 1972;220:837-841.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.